Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 1, 2007, Pages 255-263

  Cust, Anne E ^a,b,c   Kaaks, Rudolf ^a,j   Friedenreich, Christine ^d   Bonnet, Fabrice ^c,e   Laville, Martine ^c,e   Lukanova, Annekatrin ^f   Rinaldi, Sabina ^a   Dossus, Laure ^a   Slimani, Nadia ^a   Lundin, Eva ^g   Tjønneland, Anne ^h   Olsen, Anja ^h   Overvad, Kim ⁱ   Clavel Chapelon, Françoise ^e   Mesrine, Sylvie ^e   Joulin, Virginie ^e   Linseisen, Jakob ^j   Rohrmann, Sabine ^j   Pischon, Tobias ^k   Boeing, Heiner ^k   Trichopoulos, Dimitrios ^l   Trichopoulou, Antonia ^l   Benetou, Vassiliki ^l   Palli, Domenico ^m   Berrino, Franco ⁿ   Tumino, Rosario ^o   Sacerdote, Carlotta ^p   Mattiello, Amalia ^q   Quirós, J Ramón ^r   Mendez, Michelle A ^s   Sánchez, María José ^t   Larrañaga, Nerea ^u   Tormo, M J ^v   Ardanaz, Eva ^w   Bueno de Mesquita, H Bas ^x   Peeters, Petra H M ^y   Van Gils, Carla H ^y   Khaw, Kay Tee ^z   Bingham, Sheila ^z,aa   Allen, Naomi ^ab   Key, Tim ^ab   Jenab, Mazda ^a   Riboli, Elio ^ac   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITÉ LYON 1   (France)

^d Alberta Cancer Board   (Canada)

^e INSERM   (France)

^f NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UMEÅ UNIVERSITY   (Sweden)

^h INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ NATIONAL CANCER INSTITUTE   (Italy)

^o CIVILE M P AREZZO HOSPITAL   (Italy)

^p CPO Piemonte   (Italy)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r Public Health and Health Planning Directorate   (Spain)

^s CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^t ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^u Public Health Department of Gipuzkoa   (Spain)

^v DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^w INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^x NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^y UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^z UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab UNIVERSITY OF OXFORD   (United Kingdom)

^ac IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C PEPTIDE; ESTRONE SULFATE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; DEMOGRAPHY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 33846103488     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-1371     Document Type: Article

References (47)

1. Kadowaki T, Yamauchi T 2005 Adiponectin and adiponectin receptors. Endocr Rev 26:439-451
2. Kaaks R, Lukanova A, Kurzer MS 2002 Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11:1531-1543
3. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T, Otabe S, Okada T, Eto K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Nagai R, Taniyama M, Matsubara K, Yoda M, Nakano Y, Tomita M, Kimura S, Ito C, Froguel P, Kadowaki T 2002 Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536-540
4. Heinonen S, Korhonen S, Helisalmi S, Koivunen R, Tapanainen J, Hippelainen M, Laakso M 2005 Associations between two single nucleotide polymorphisms in the adiponectin gene and polycystic ovary syndrome. Gynecol Endocrinol 21:165-169
5. Lihn AS, Pedersen SB, Richelsen B 2005 Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13-21
6. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T 2001 The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941-946
7. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y 2002 Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737
8. Takemura Y, Osuga Y, Yamauchi T, Kobayashi M, Harada M, Hirata T, Morimoto C, Hirota Y, Yoshino O, Koga K, Yano T, Kadowaki T, Taketani Y 2006 Expression of adiponectin receptors and its possible implication in the human endometrium. Endocrinology 147:3203-3210
9. Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y 2003 Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107:671-674
10. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
11. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G 2003 Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 52:1779-1785
12. Yokota T, Oritani K, Takahashi I, Ishikawa J, Matsuyama A, Ouchi N, Kihara S, Funahashi T, Tenner AJ, Tomiyama Y, Matsuzawa Y 2000 Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723-1732
13. Kelesidis I, Kelesidis T, Mantzoros CS 2006 Adiponectin and cancer: a systematic review. Br J Cancer 94:1221-1225
14. Modugno F, Ness RB, Chen C, Weiss NS 2005 Inflammation and endometrial cancer: a hypothesis. Cancer Epidemiol Biomarkers Prev 14:2840-2847
15. Reed MJ, Purohit A 1997 Breast cancer and the role of cytokines in regulating estrogen synthesis: an emerging hypothesis. Endocr Rev 18:701-715
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
17. Petridou E, Mantzoros C, Dessypris N, Koukoulomatis P, Addy C, Voulgaris Z, Chrousos G, Trichopoulos D 2003 Plasma adiponectin concentrations in relation to endometrial cancer: a case-control study in Greece. J Clin Endocrinol Metab 88:993-997
18. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS, La Vecchia C 2004 Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 89:1160-1163
19. Soliman PT, Wu D, Tortolero-Luna G, Schmeler KM, Slomovitz BM, Bray MS, Gershenson DM, Lu KH 2006 Association between adiponectin, insulin resistance, and endometrial cancer. Cancer 106:2376-2381
20. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R 2002 European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5:1113-1124
21. Haftenberger M, Lahmann PH, Panico S, Gonzalez CA, Seidell JC, Boeing H, Giurdanella MC, Krogh V, Bueno-de-Mesquita HB, Peeters PH, Skeie G, Hjartaker A, Rodriguez M, Quiros JR, Berglund G, Janlert U, Khaw KT, Spencer EA, Overvad K, Tjonneland A, Clavel-Chapelon F, Tehard B, Miller AB, Klipstein-Grobusch K, Benetou V, Kiriazi G, Riboli E, Slimani N 2002 Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1147-1162
22. Haftenberger M, Schuit AJ, Tormo MJ, Boeing H, Wareham N, Bueno-de-Mesquita HB, Kumle M, Hjartaker A, Chirlaque MD, Ardanaz E, Andren C, Lindahl B, Peeters PH, Allen NE, Overvad K, Tjonneland A, Clavel-Chapelon F, Linseisen J, Bergmann MM, Trichopoulou A, Lagiou P, Salvini S, Panico S, Riboli E, Ferrari P, Slimani N 2002 Physical activity of subjects aged 50-64 years involved in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 5:1163-1176
23. Verheus M, Peeters PH, Rinaldi S, Dossus L, Biessy C, Olsen A, Tjonneland A, Overvad K, Jeppesen M, Clavel-Chapelon F, Tehard B, Nagel G, Linseisen J, Boeing H, Lahmann PH, Arvaniti A, Psaltopoulou T, Trichopoulou A, Palli D, Tumino R, Panico S, Sacerdote C, Sieri S, van Gils CH, Bueno-de-Mesquita BH, Gonzalez CA, Ardanaz E, Larranaga N, Garcia CM, Navarro C, Quiros JR, Key T, Allen N, Bingham S, Khaw KT, Slimani N, Riboli E, Kaaks R 2006 Serum C-peptide levels and breast cancer risk: Results from the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer 119:659-667
24. Beral V, Bull D, Reeves G 2005 Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543-1551
25. World Health Organization 2003 Pathology and genetics - tumours of the breast and female genital organs. In: Tavassoli FA, Devilee P, eds. World Health Organization classification of tumours. Lyon, France: IARC Press; 217-258
26. Sherman ME 2000 Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13:295-308
27. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E 2005 Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755-765
28. Richardson DB 2004 An incidence density sampling program for nested case-control analyses. Occup Environ Med 61:e59
29. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P 2006 Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 15:401-402
30. Pischon T, Hotamisligil GS, Rimm EB 2003 Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 49:650-652
31. Gavrila A, Chan JL, Yiannakouris N, Kontogianni M, Miller LC, Orlova C, Mantzoros CS 2003 Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 88:4823-4831
32. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE 2004 Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 279:12152-12162
33. Trujillo ME, Scherer PE 2005 Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257:167-175
34. Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R 2004 Prediagnostic levels of C-peptide, IGF-I, IGFBP-1, -2 and -3 and risk of endometrial cancer. Int J Cancer 108:262-268
35. Furberg AS, Thune I 2003 Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort. Int J Cancer 104:669-676
36. Nagamani M, Stuart CA 1998 Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 179:6-12
37. Luo Z, Saha AK, Xiang X, Ruderman NB 2005 AMPK, the metabolic syndrome and cancer. Trends Pharmacol Sci 26:69-76
38. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y 2004 Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101:2476-2481
39. Wang Y, Lam KS, Xu JY, Lu G, Xu LY, Cooper GJ, Xu A 2005 Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner. J Biol Chem 280:18341-18347
40. Bergman RN, Mittelman SD 1998 Central role of the adipocyte in insulin resistance. J Basic Clin Physiol Pharmacol 9:205-221
41. Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM, Reaven PD 2004 Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53:585-590
42. White E 1997 Effects of biomarker measurement error on epidemiological studies. In: Toniolo P, Boffeta P, Shuker DEG, Rothman N, Hulka B, Pearce N, eds. Application of biomarkers in cancer epidemiology. IARC Sci Publ (Lyon) 142;73-93
43. Vainio H, Bianchini F, eds. 2002 Weight control and physical activity - IARC handbook for cancer prevention. Vol. 6. Lyon, France: IARC Press; 5-6
44. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B 2003 Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 285:E527-E533
45. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM 2001 Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 86:3815-3819
46. Bluher M, Bullen Jr JW, Lee JH, Kralisch S, Fasshauer M, Kloting N, Niebauer J, Schon MR, Williams CJ, Mantzoros CS 2006 Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. J Clin Endocrinol Metab 91:2310-2316
47. Pischon T, Girman CJ, Rifai N, Hotamisligil GS, Rimm EB 2005 Association between dietary factors and plasma adiponectin concentrations in men. Am J Clin Nutr 81:780-786